Theravance Biopharma, Inc. (TBPH)
16.25
-0.10
(-0.61%)
USD |
NASDAQ |
Apr 13, 12:54
Theravance Biopharma Accounts Payable (Quarterly) : 2.568M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Integer Holdings Corp. | 113.13M |
| QuidelOrtho Corp. | 279.40M |
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| Relmada Therapeutics, Inc. | 1.569M |
| Avalo Therapeutics, Inc. | 0.137M |